| Financial Year |
March 31 2023 |
| Monetary Funds |
467,287,997.37 |
| Held-for-trading Financial Assets |
17,760,743.42 |
| Notes Receivable |
19,920,023.94 |
| Accounts Receivable |
508,286,333.19 |
| Advances to Suppliers |
242,390,490.56 |
| Other Receivables |
34,138,572.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,407,141,942.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,268,199.06 |
| Total Current Assets |
3,712,194,302.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
26,949,570.67 |
| Investment Properties |
40,663,554.90 |
| Fixed Assetes |
2,306,907,764.55 |
| Under-construction Projects |
789,800,772.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
236,586,660.32 |
| R&D expenses |
-- |
| Goodwill |
116,973,889.57 |
| Long-Term Deferred and Prepaid Expenses |
18,204,612.44 |
| Deferred Income Tax Assets |
53,595,125.67 |
| Other Non-Current Assets |
75,067,585.93 |
| Sub-Total of Non-Current Assets |
4,088,940,462.16 |
| Total Assets |
7,801,134,764.85 |
| Short-Term Loans |
1,801,994,831.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
954,410,586.62 |
| Accounts Payable |
726,926,531.13 |
| Accounts Received In Advance |
298,238.19 |
| Employee Compensation Payable |
42,216,484.59 |
| Taxes Payable |
24,345,937.82 |
| Interest Payable |
-- |
| Dividend Payable |
358,527.35 |
| Other payables |
146,837,989.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
374,298,762.26 |
| Other Current Liabilities |
12,737,163.12 |
| Sub-Total of Current Liabilities |
4,223,840,545.77 |
| Long-term Loans |
721,201,566.18 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
85,757,365.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
39,890,899.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,125,781,572.32 |
| Total Liabilities |
5,349,622,118.09 |
| Paid-In Capital(Or Share Stock) |
436,134,976.00 |
| Capital Surplus |
892,875,614.93 |
| Surplus Reserve |
102,548,354.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
602,836,402.18 |
| Minority Stockholder's Interest |
410,471,687.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,041,040,959.20 |
| Owner's Equity（Stockholder's Equity） |
2,451,512,646.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,801,134,764.85 |
